SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-004379
Filing Date
2023-02-24
Accepted
2023-02-24 16:16:45
Documents
58
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-20221231.htm   iXBRL 10-K 3101572
2 EX-23.1 abio-ex23_1.htm EX-23 4244
3 EX-31.1 abio-ex31_1.htm EX-31 16135
4 EX-31.2 abio-ex31_2.htm EX-31 16009
5 EX-32.1 abio-ex32_1.htm EX-32 13717
  Complete submission text file 0000950170-23-004379.txt   7928639

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abio-20221231_cal.xml EX-101.CAL 39440
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abio-20221231_pre.xml EX-101.PRE 268708
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abio-20221231_lab.xml EX-101.LAB 403645
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abio-20221231.xsd EX-101.SCH 36211
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abio-20221231_def.xml EX-101.DEF 114296
52 EXTRACTED XBRL INSTANCE DOCUMENT abio-20221231_htm.xml XML 1082130
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 23667512
SIC: 2835 In Vitro & In Vivo Diagnostic Substances